ReShape Lifesciences Inc (RSLS) — Financial Flexibility Index
ReShape Lifesciences Inc (RSLS) has a Financial Flexibility Index of -1.40x as of June 2025. Free cash flow of $-4.49 Million (operating CF $-4.49 Million minus capex $0.00) represents -1% of total liabilities ($3.20 Million). Also explore ReShape Lifesciences Inc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ReShape Lifesciences Inc Financial Flexibility Index (2005–2024)
Historical Financial Flexibility Index trend for ReShape Lifesciences Inc across 20 annual periods. Check ReShape Lifesciences Inc (RSLS) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for ReShape Lifesciences Inc (2005–2024)
Year-by-year free cash flow to debt coverage for ReShape Lifesciences Inc. For the full company profile including market capitalisation, see market value of ReShape Lifesciences Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.88x | $-4.43 Million | $-4.43 Million | $5.05 Million | ▲ +79.3% |
| 2023 | -4.23x | $-16.92 Million | $-16.96 Million | $4.00 Million | ▼ -45.3% |
| 2022 | -2.91x | $-21.77 Million | $-21.90 Million | $7.48 Million | ▼ -58.6% |
| 2021 | -1.84x | $-15.02 Million | $-15.38 Million | $8.19 Million | ▼ -407.7% |
| 2020 | -0.36x | $-8.16 Million | $-8.55 Million | $22.57 Million | ▲ +60.4% |
| 2019 | -0.91x | $-14.19 Million | $-14.20 Million | $15.55 Million | ▲ +51.4% |
| 2018 | -1.88x | $-27.44 Million | $-27.49 Million | $14.61 Million | ▲ +5.2% |
| 2017 | -1.98x | $-24.45 Million | $-24.59 Million | $12.34 Million | ▲ +60.6% |
| 2016 | -5.03x | $-20.64 Million | $-20.66 Million | $4.10 Million | ▼ -76.5% |
| 2015 | -2.85x | $-22.57 Million | $-22.61 Million | $7.91 Million | ▼ -14.1% |
| 2014 | -2.50x | $-19.29 Million | $-19.38 Million | $7.72 Million | ▼ -62.5% |
| 2013 | -1.54x | $-18.01 Million | $-18.43 Million | $11.71 Million | ▲ +2.4% |
| 2012 | -1.58x | $-22.40 Million | $-22.48 Million | $14.22 Million | ▲ +0.4% |
| 2011 | -1.58x | $-19.68 Million | $-19.94 Million | $12.44 Million | ▼ -4.0% |
| 2010 | -1.52x | $-13.66 Million | $-13.66 Million | $8.98 Million | ▲ +33.9% |
| 2009 | -2.30x | $-24.47 Million | $-24.66 Million | $10.63 Million | ▼ -16.2% |
| 2008 | -1.98x | $-33.42 Million | $-33.67 Million | $16.87 Million | ▼ -20.9% |
| 2007 | -1.64x | $-22.57 Million | $-23.37 Million | $13.77 Million | ▲ +21.3% |
| 2006 | -2.08x | $-15.59 Million | $-16.23 Million | $7.49 Million | ▼ -103.1% |
| 2005 | -1.03x | $-9.83 Million | $-10.28 Million | $9.59 Million | — |